Naba Alsaha Medical Services Company (9546.SR) — Cash flow
Operating, investing, and financing cash flow for Naba Alsaha Medical Services Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 31↑40.6% | 22↓58.4% | 52↑81.0% | 29↑5.1% | 28 | |
| Depreciation & Amortization | 12↑7.0% | 11↑15.8% | 9↑40.3% | 7↑10.5% | 6 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -16↓234.5% | -5↑82.1% | -26↓1319.8% | -2↑32.3% | -3 | |
| Accounts Receivable | -17↓203.4% | 16↑131.3% | -52↓3170.6% | 2↑248.8% | -1 | |
| Inventory | 0.72↓6.1% | 0.77↑117.2% | -4↓1804.1% | 0.26↑133.5% | -0.79 | |
| Accounts Payable | 0.00↑100.0% | -14↓184.2% | 17↑924.7% | -2↓185.9% | 2 | |
| Other Working Capital | 0.32↑104.5% | -7↓155.7% | 13↑855.4% | -2↑47.3% | -3 | |
| Other Non-Cash Items | 0.01↓99.8% | 8↑216.2% | -6↓496.2% | 2↑909.5% | -0.20 | |
| Net Cash from Operating Activities | 27↓24.8% | 36↑21.4% | 29↓17.3% | 36↑15.5% | 31 | |
| Operating Cash Flow | 27↓24.8% | 36↑21.4% | 29↓17.3% | 36↑15.5% | 31 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -77↓99.2% | -39↑0.1% | -39↓251.6% | -11↓6.7% | -10 | |
| Capital Expenditure | -78↓103.1% | -38↑7.5% | -42↓275.5% | -11↓6.7% | -10 | |
| Acquisitions | -2 | 0.00↑100.0% | -18↓540.1% | -3 | 0.00 | |
| Purchases of Investments | -0.90 | 0.00↑100.0% | -1↑64.7% | -3 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | -0.63 | 0.00↑100.0% | -3↓193.2% | 3 | 0.00 | |
| Net Cash from Investing Activities | -81↓108.6% | -39↑36.0% | -61↓336.6% | -14↓33.9% | -10 | |
| Financing Activities | ||||||
| Net Debt Issuance | 36↓14.4% | 42↑54.8% | 27↑346.0% | -11↑18.4% | -13 | |
| Long-Term Net Debt Issuance | 36↓14.4% | 42↑54.8% | 27↑346.0% | -11↑18.4% | -13 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -3 | 0.00↑100.0% | -2↑0.0% | -2 | 0.00 | |
| Common Dividends Paid | -3 | 0.00↑100.0% | -2↑0.0% | -2 | 0.00 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -2↓37.1% | -2↑5.8% | -2↓6.1% | -2↑0.0% | -2 | |
| Net Cash from Financing Activities | 30↓24.4% | 40↑73.5% | 23↑256.7% | -15↑2.5% | -15 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -24↓164.2% | 37↑558.3% | -8↓218.3% | 7↑31.2% | 5 | |
| Cash at Beginning of Period | 43↑644.6% | 6↓58.4% | 14↑97.7% | 7↑291.7% | 2 | |
| Cash at End of Period | 19↓55.6% | 43↑644.6% | 6↓58.4% | 14↑97.7% | 7 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -51↓1758.7% | -3↑77.3% | -12↓149.7% | 24↑20.0% | 20 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.